Phase I Pharmacokinetic Study (SALBLOCK)
NCT01564199
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteer Study
Interventions
DRUG:
salmeterol / fluticasone propionate
Sponsor
Orion Corporation, Orion Pharma